tm logo

Monitor this mark

View On USPTO

SEAGEN
Live/Registered
SECTION 8-ACCEPTED

accepted

on 06 Nov 2023

Last Applicant/ Owned by

SEAGEN INC.

21823 30TH DRIVE S.E.

BOTHELL

WA

98021

Serial Number

86103387 filed on 28th Oct 2013

Registration Number

5251440 registered on 25th Jul 2017

in the Principal Register

Correspondent Address

Heather A. McDonald

Heather A. McDonald Pfizer Inc.

New York, NY 10001-2192

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SEAGEN

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER AND IMMUNOLOGICAL DISEASES

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER AND IMMUNOLOGICAL DISEASES

First Use Date in General

17th May 2017

First Use Date in Commerce

17th May 2017

Mark Details

Serial Number

No 86103387

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T 444929

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
11th Jul 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11th Jul 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11th Jul 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
11th Jul 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11th Jul 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd May 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd May 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd May 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06th Nov 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06th Nov 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED